Autolus Therapeutics plc
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | 100.0% | 100.0% | – | 100.0% | 100.0% | 100.0% | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 1,246.7% | 795.9% | 795.9% | 1,108.4% | 1,108.4% | 2,616.6% | 2,729.3% | 2,000.7% | 3,288.6% | 5,984.1% | 1,148.9% | 7,743.5% | 9,195.3% | 9,504.2% | 9,256.5% | 10,692.2% | 4,933.1% | 9,586.1% | 11,424.2% | 1,953.3% | 13,683.1% | 22,019.4% | 1,245.2% | – | 1,588.5% | 44.8% | 147.0% | – | 375.6% | 100.0% | 17.9% | – | – | 476,910.3% | 199.9% | 116.8% | 135.1% | 104.3% | 93.7% | 44.8% | 84.3% | |
| -761.1% | -695.9% | -695.9% | -1,008.4% | -1,008.4% | -2,516.6% | -2,629.3% | -1,900.7% | -3,188.6% | -5,884.1% | -1,048.9% | -7,643.5% | -9,095.3% | -9,404.2% | -9,156.5% | -10,592.2% | -4,833.1% | -9,486.1% | -11,324.2% | -1,853.3% | -13,583.1% | -21,919.4% | -1,245.2% | – | -1,488.5% | 55.2% | -47.0% | – | -275.6% | -100.0% | 82.1% | – | – | -476,810.3% | -99.9% | -16.8% | -35.1% | -4.3% | 6.3% | 55.2% | 15.7% | |
| 861.1% | 795.9% | 795.9% | 1,133.0% | 1,133.0% | 0.0% | 2,744.6% | 2,000.7% | 3,305.9% | 5,984.1% | 1,148.9% | 7,743.5% | 9,195.3% | 9,495.5% | 9,264.8% | 10,705.5% | 4,941.8% | 9,579.7% | 11,424.2% | 1,953.3% | 13,683.1% | 22,075.0% | 20,459.6% | – | 1,588.5% | 698.3% | 2,119.8% | – | 7,960.1% | 1,417.4% | 303.9% | – | – | 174,241.4% | 297.6% | 131.1% | 131.6% | 146.7% | 80.9% | 61.1% | 95.9% | |
| 425.1% | 377.6% | 377.6% | 710.8% | 710.8% | 1,128.3% | 1,016.4% | 1,535.7% | 2,369.1% | 2,565.2% | 486.6% | 3,363.9% | 2,897.3% | 2,728.2% | 2,252.7% | 2,904.1% | 1,447.5% | 2,229.2% | 3,127.9% | 439.9% | 3,516.5% | 3,474.4% | 4,811.4% | – | 347.4% | 193.8% | 718.6% | – | 2,613.5% | 886.1% | 180.1% | – | – | 232,448.3% | 328.8% | 144.6% | 171.2% | 147.6% | 152.4% | 90.1% | 130.5% | |
| 1,286.1% | 379.3% | 379.3% | 714.7% | 714.7% | 3,744.9% | 1,706.8% | 386.7% | 1,976.2% | 8,549.3% | 1,635.5% | 11,107.4% | 12,092.6% | 12,706.1% | 11,517.5% | 13,609.6% | 6,389.3% | 11,808.9% | 14,672.5% | 2,393.2% | 17,199.6% | 26,292.2% | 24,025.9% | – | 1,936.0% | 847.3% | 2,691.4% | – | 10,573.6% | 2,203.4% | 466.2% | – | – | 355,693.1% | 626.5% | 275.7% | 302.8% | 294.1% | 233.3% | 151.2% | 226.4% | |
| -1,186.1% | -1,073.6% | -1,073.6% | -1,719.2% | -1,719.2% | -3,644.9% | -3,645.8% | -3,436.3% | -5,557.7% | -8,449.3% | -1,535.5% | -11,007.4% | -11,992.6% | -22,110.4% | -20,674.0% | -24,201.7% | -11,222.4% | -21,295.0% | -25,996.7% | -4,246.4% | -30,782.6% | -48,211.7% | -25,271.1% | – | -3,424.5% | -792.1% | -2,738.4% | – | -10,849.3% | -2,303.4% | -384.1% | – | – | -832,503.4% | -726.3% | -292.6% | -337.9% | -298.3% | -227.0% | -95.9% | -210.8% | |
| 1.0% | 0.0% | 0.0% | 0.0% | 6.5% | 0.0% | 0.0% | 0.0% | 0.0% | 149.7% | 22.6% | 1,613.3% | 1,270.0% | 1,886.4% | 1,477.5% | 16.0% | 363.5% | 275.2% | 171.7% | 109.8% | 414.8% | 613.9% | 1,078.3% | – | 78.1% | 90.4% | 379.6% | – | 1,235.0% | 1,697.4% | 191.0% | – | – | 106,327.6% | 112.9% | 32.6% | 49.6% | 94.0% | 42.4% | 5.9% | 40.1% | |
| -1,182.1% | -1,069.1% | -1,069.1% | -1,719.3% | -1,719.3% | -4,125.1% | -4,268.3% | -2,227.3% | -4,905.5% | -7,855.7% | -1,558.0% | -9,394.1% | -10,722.6% | -11,999.7% | -7,744.7% | -8,540.6% | -4,330.9% | -11,990.6% | -14,494.4% | -2,403.0% | -16,684.7% | -26,717.8% | -25,714.5% | – | -2,065.0% | -695.2% | -3,082.4% | – | -11,298.0% | -3,651.3% | -522.2% | – | – | -90,151.7% | -756.4% | -227.1% | -370.8% | -376.8% | -269.8% | -84.6% | -238.0% | |
| -146.6% | -207.4% | -207.4% | -224.9% | -224.9% | -435.8% | -344.1% | -500.5% | -716.6% | -880.1% | -174.2% | -968.6% | -1,548.1% | 1,250.8% | 1,093.5% | 2,396.2% | 1,156.6% | -1,381.4% | -2,127.9% | -386.4% | -2,281.8% | -3,570.0% | -3,388.0% | – | -259.7% | 9.4% | -1.1% | – | -5.2% | 696.4% | -0.1% | – | – | 5,041.4% | 24.8% | 1.9% | 2.5% | -4.9% | 3.3% | 1.0% | 0.6% | |
| -1,035.5% | -861.7% | -861.7% | -1,494.5% | -1,494.5% | -3,689.3% | -3,924.2% | -1,726.9% | -4,188.9% | -6,975.7% | -1,383.9% | -8,425.4% | -9,174.4% | -13,250.5% | -8,838.2% | -10,936.9% | -5,487.5% | -10,609.2% | -12,366.5% | -2,016.6% | -14,403.0% | -23,147.8% | -22,326.5% | – | -1,805.3% | -704.6% | -3,081.3% | – | -11,292.9% | -4,347.7% | -522.1% | – | – | -95,193.1% | -781.1% | -229.0% | -373.3% | -371.9% | -273.1% | -85.6% | -238.6% | |
| – | -1,056.6% | -1,056.4% | -1,689.8% | -1,657.1% | – | -3,550.9% | -3,319.4% | -5,421.2% | -8,231.4% | -1,452.0% | -10,847.3% | -11,608.1% | -12,212.9% | -11,036.1% | -13,063.8% | -6,064.7% | -11,326.5% | -13,954.6% | -2,156.8% | -16,062.3% | -25,017.8% | -23,391.0% | – | -1,760.5% | -560.1% | -2,555.8% | – | -10,134.0% | -1,853.9% | -313.4% | – | – | -254,437.9% | -618.1% | -206.5% | -305.3% | -271.9% | -217.2% | -74.0% | -188.7% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.